von Blomberg BM - Search Results

1

IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.

Moreno M, Molling JW, von Mensdorff-Pouilly S, Verheijen RH, Hooijberg E, Kramer D, Reurs AW, van den Eertwegh AJ, von Blomberg BM, Scheper RJ, Bontkes HJ. Moreno M, et al. Among authors: von blomberg bm, von mensdorff pouilly s. J Immunol. 2008 Aug 15;181(4):2446-54. doi: 10.4049/jimmunol.181.4.2446. J Immunol. 2008. PMID: 18684935

2

Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.

van der Vliet HJ, von Blomberg BM, Hazenberg MD, Nishi N, Otto SA, van Benthem BH, Prins M, Claessen FA, van den Eertwegh AJ, Giaccone G, Miedema F, Scheper RJ, Pinedo HM. van der Vliet HJ, et al. Among authors: von blomberg bm. J Immunol. 2002 Feb 1;168(3):1490-5. doi: 10.4049/jimmunol.168.3.1490. J Immunol. 2002. PMID: 11801694

3

Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.

van der Vliet HJ, Molling JW, von Blomberg BM, Kölgen W, Stam AG, de Gruijl TD, Mulder CJ, Janssen HL, Nishi N, van den Eertwegh AJ, Scheper RJ, van Nieuwkerk CJ. van der Vliet HJ, et al. Among authors: von blomberg bm. Clin Immunol. 2005 Feb;114(2):183-9. doi: 10.1016/j.clim.2004.10.001. Clin Immunol. 2005. PMID: 15639652

4

Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.

Molling JW, Kölgen W, van der Vliet HJ, Boomsma MF, Kruizenga H, Smorenburg CH, Molenkamp BG, Langendijk JA, Leemans CR, von Blomberg BM, Scheper RJ, van den Eertwegh AJ. Molling JW, et al. Among authors: von blomberg bm. Int J Cancer. 2005 Aug 10;116(1):87-93. doi: 10.1002/ijc.20998. Int J Cancer. 2005. PMID: 15756674

5

Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection.

van der Vliet HJ, van Vonderen MG, Molling JW, Bontkes HJ, Reijm M, Reiss P, van Agtmael MA, Danner SA, van den Eertwegh AJ, von Blomberg BM, Scheper RJ. van der Vliet HJ, et al. Among authors: von blomberg bm. J Immunol. 2006 Nov 1;177(9):5775-8. doi: 10.4049/jimmunol.177.9.5775. J Immunol. 2006. PMID: 17056500

6

Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.

Molling JW, Langius JA, Langendijk JA, Leemans CR, Bontkes HJ, van der Vliet HJ, von Blomberg BM, Scheper RJ, van den Eertwegh AJ. Molling JW, et al. Among authors: von blomberg bm. J Clin Oncol. 2007 Mar 1;25(7):862-8. doi: 10.1200/JCO.2006.08.5787. J Clin Oncol. 2007. PMID: 17327607

7

Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.

Molling JW, Moreno M, van der Vliet HJ, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJ. Molling JW, et al. Among authors: von blomberg bm. J Immunol Methods. 2007 Apr 30;322(1-2):70-81. doi: 10.1016/j.jim.2007.02.002. Epub 2007 Feb 23. J Immunol Methods. 2007. PMID: 17343874

8

Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases.

Molling JW, Moreno M, de Groot J, van der Vliet HJ, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJ. Molling JW, et al. Among authors: von blomberg bm. Immunol Lett. 2008 Jun 15;118(1):36-43. doi: 10.1016/j.imlet.2008.02.007. Epub 2008 Mar 24. Immunol Lett. 2008. PMID: 18405982

9

Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC).

Moreno M, Mol BM, von Mensdorff-Pouilly S, Verheijen RH, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJ. Moreno M, et al. Among authors: von blomberg bm, von mensdorff pouilly s. Cancer Lett. 2008 Dec 8;272(1):70-6. doi: 10.1016/j.canlet.2008.06.028. Epub 2008 Aug 5. Cancer Lett. 2008. PMID: 18684557

10

In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.

Moreno M, Molling JW, von Mensdorff-Pouilly S, Verheijen RH, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJ. Moreno M, et al. Among authors: von blomberg bm, von mensdorff pouilly s. Clin Immunol. 2008 Oct;129(1):145-54. doi: 10.1016/j.clim.2008.07.004. Epub 2008 Aug 15. Clin Immunol. 2008. PMID: 18707922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters